Source Type: Clinical Trial

May 1, 2025

An open-label phase 1 pilot trial in ten older adults with mild cognitive impairment or early Alzheimer's dementia: eight weeks…

December 1, 2025

A single-arm, open-label pilot trial in 14 people with early Alzheimer's disease: six months of weekly oral rapamycin was tolerated,…